We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.47B
AUM Growth
+$309M
Cap. Flow
+$259M
Cap. Flow %
17.55%
Top 10 Hldgs %
27.29%
Holding
179
New
33
Increased
51
Reduced
54
Closed
39

Top Buys

Rank Stock Value
1
APP icon
Applovin
APP
+$58.8M
2
LYFT icon
Lyft
LYFT
+$27.4M
3
CLVT icon
Clarivate
CLVT
+$26.3M
4
FTDR icon
Frontdoor
FTDR
+$24.5M
5
CRM icon
Salesforce
CRM
+$23.3M

Sector Composition

Rank Sector Weight
1 Technology 31.82%
2 Consumer Discretionary 14.98%
3 Communication Services 13.53%
4 Healthcare 8.23%
5 Industrials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIR
176
DELISTED
CIRCOR International, Inc
CIR
-135,265
Closed -$2.23M
ARNC
177
DELISTED
Arconic Corporation
ARNC
-68,821
Closed -$1.17M
HYRE
178
DELISTED
HyreCar Inc. Common Stock
HYRE
-502,881
Closed -$463K
POSH
179
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
-1,337,231
Closed -$21M

Similar funds

Invenomic Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Invenomic Capital Management held 179 positions worth $1.47B, up 27% from $1.16B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Invenomic Capital Management deployed $259M of net new capital in Q4 2022, opening 33 new positions and adding to 51 existing holdings. Its largest new stake was Clarivate: 2,805,166 shares worth $23.4M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Universal Health Services, an estimated $22.3M trimmed.

  • Invenomic Capital Management's largest Q4 2022 buy was Clarivate: 2,805,166 shares worth $23.4M.
  • Invenomic Capital Management added most to Applovin in Q4 2022, an estimated $58.8M increase.
  • Invenomic Capital Management's biggest Q4 2022 reduction was Universal Health Services, cutting an estimated $22.3M.
  • Invenomic Capital Management fully exited Cisco in Q4 2022, selling an estimated $27.1M.
  • Invenomic Capital Management's ten largest holdings make up 27% of its $1.47B portfolio in Q4 2022.
  • Invenomic Capital Management opened 33 new positions and closed 39 in Q4 2022.
  • Invenomic Capital Management's portfolio value rose 27% quarter-over-quarter to $1.47B.

Based on Invenomic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.